19-41357916-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_030578.4(B9D2):c.195C>T(p.Phe65Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,614,138 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0026 ( 5 hom. )
Consequence
B9D2
NM_030578.4 synonymous
NM_030578.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00100
Publications
4 publications found
Genes affected
B9D2 (HGNC:28636): (B9 domain containing 2) This gene encodes a B9 domain protein, which are exclusively found in ciliated organisms. The gene is upregulated during mucociliary differentiation, and the encoded protein localizes to basal bodies and cilia. Disrupting expression of this gene results in ciliogenesis defects. [provided by RefSeq, Oct 2009]
TMEM91 (HGNC:32393): (transmembrane protein 91) Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle and membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 19-41357916-G-A is Benign according to our data. Variant chr19-41357916-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.001 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00253 (386/152302) while in subpopulation AMR AF = 0.00543 (83/15292). AF 95% confidence interval is 0.00449. There are 1 homozygotes in GnomAd4. There are 184 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| B9D2 | NM_030578.4 | c.195C>T | p.Phe65Phe | synonymous_variant | Exon 3 of 4 | ENST00000243578.8 | NP_085055.2 | |
| B9D2 | XM_011527349.3 | c.195C>T | p.Phe65Phe | synonymous_variant | Exon 3 of 4 | XP_011525651.1 | ||
| B9D2 | XM_011527350.3 | c.36C>T | p.Phe12Phe | synonymous_variant | Exon 2 of 3 | XP_011525652.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| B9D2 | ENST00000243578.8 | c.195C>T | p.Phe65Phe | synonymous_variant | Exon 3 of 4 | 1 | NM_030578.4 | ENSP00000243578.2 |
Frequencies
GnomAD3 genomes AF: 0.00254 AC: 386AN: 152184Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
386
AN:
152184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00205 AC: 516AN: 251374 AF XY: 0.00200 show subpopulations
GnomAD2 exomes
AF:
AC:
516
AN:
251374
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00263 AC: 3845AN: 1461836Hom.: 5 Cov.: 34 AF XY: 0.00259 AC XY: 1882AN XY: 727218 show subpopulations
GnomAD4 exome
AF:
AC:
3845
AN:
1461836
Hom.:
Cov.:
34
AF XY:
AC XY:
1882
AN XY:
727218
show subpopulations
African (AFR)
AF:
AC:
22
AN:
33480
American (AMR)
AF:
AC:
92
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
5
AN:
86256
European-Finnish (FIN)
AF:
AC:
28
AN:
53414
Middle Eastern (MID)
AF:
AC:
10
AN:
5754
European-Non Finnish (NFE)
AF:
AC:
3552
AN:
1111980
Other (OTH)
AF:
AC:
132
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
213
426
640
853
1066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00253 AC: 386AN: 152302Hom.: 1 Cov.: 31 AF XY: 0.00247 AC XY: 184AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
386
AN:
152302
Hom.:
Cov.:
31
AF XY:
AC XY:
184
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
28
AN:
41568
American (AMR)
AF:
AC:
83
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
3
AN:
10618
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
257
AN:
68024
Other (OTH)
AF:
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
B9D2: BP4, BP7
Dec 05, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Dec 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.